ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 872,48
-0,32%
Dow Jones
44 713,52
-0,31%
DAX
21 637,53
0,93%
Brent Oil
75,55
-0,49%
Bitcoin
105 194,87
1,40%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Dominari Holdings Inc (DOMH) Cours

Dominari Holdings Inc

Dominari Holdings Inc (DOMH)

NASDAQ
2,27
0,275
(13,78%)
Fermé 30 Janvier 10:00PM
Retardé de 15 minutes
2,20
-0,07
(-3,08%)
Après les heures de négociation: 12:55AM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
2,20
Prix Achat
2,15
Prix Vente
2,19
Volume échangé
198 429
1,86 Fourchette du Jour 2,27
0,8258 Plage de 52 semaines 3,20
Cap du marché
13,808M
Clôture Veille
1,995
Ouverture
1,98
Dernière Transaction
2
@
2.1505
Dernière heure de transaction
Volume financier
US$ 400 200
VWAP
2,0168
Volume moyen (3 m)
57 935
Actions en circulation
6 276 138
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,45
Bénéfice par action (BPA)
-3,65
Chiffre d'affairess
2,04M
Bénéfice net
-22,88M

À propos de Dominari Holdings Inc

Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including t... Dominari Holdings Inc formerly, AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Show more

Secteur
Security Brokers & Dealers
Industrie
Security Brokers & Dealers
Site Web
www.dominariholdings.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Dominari Holdings Inc est coté dans le secteur Security Brokers & Dealers de la NASDAQ avec le ticker DOMH. Le dernier cours de clôture d'Dominari était de US$2,00. Au cours de la dernière année, les actions de Dominari ont été négociées dans une fourchette de prix de US$ 0,8258 à US$ 3,20.

Dominari compte actuellement 6 276 138 actions en circulation. La capitalisation boursière d'Dominari est de US$12,52 million. Dominari a un ratio cours/bénéfice (ratio PE) de -0.45.

DOMH Dernières nouvelles

Plus de nouvelles

Form 3 - Initial statement of beneficial ownership of securities

il y a 7 heures
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

21 Janvier 2025
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

03 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Janvier 2025
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

23 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Décembre 2024
Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933

13 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 Novembre 2024
Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

25 Septembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.857.14285714291.42.271.34753450741.91091714CS
41.22124.4897959180.982.270.9610011340101.63516092CS
120.4928.65497076021.712.270.8258579351.50509482CS
260.44251.762.270.8258309301.56561828CS
52-0.01-0.4524886877832.213.20.8258208851.75891647CS
156-1.01-31.46417445483.214.450.8258188272.39873493CS
260-1.01-31.46417445483.214.450.8258188272.39873493CS

DOMH - Frequently Asked Questions (FAQ)

What is the current Dominari share price?
The current share price of Dominari is US$ 2,20
How many Dominari shares are in issue?
Dominari has 6 276 138 shares in issue
What is the market cap of Dominari?
The market capitalisation of Dominari is USD 12,52M
What is the 1 year trading range for Dominari share price?
Dominari has traded in the range of US$ 0,8258 to US$ 3,20 during the past year
What is the PE ratio of Dominari?
The price to earnings ratio of Dominari is -0,45
What is the cash to sales ratio of Dominari?
The cash to sales ratio of Dominari is 5,02
What is the reporting currency for Dominari?
Dominari reports financial results in USD
What is the latest annual turnover for Dominari?
The latest annual turnover of Dominari is USD 2,04M
What is the latest annual profit for Dominari?
The latest annual profit of Dominari is USD -22,88M
What is the registered address of Dominari?
The registered address for Dominari is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Dominari website address?
The website address for Dominari is www.dominariholdings.com
Which industry sector does Dominari operate in?
Dominari operates in the SECURITY BROKERS & DEALERS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
DGNXDiginex Ltd
US$ 49,18
(228,09%)
3,34M
SLXNSilexion Therapeutics Corporation
US$ 3,1301
(131,86%)
330,45M
KRKR36Kr Holdings Inc
US$ 9,10
(114,12%)
23,61M
SPGCSacks Parente Golf Inc
US$ 0,6001
(57,92%)
52,17M
XFORX4 Pharmaceuticals Inc
US$ 0,7542
(56,54%)
42,49M
ZKINZK International Group Co Ltd
US$ 0,4813
(-41,21%)
3,1M
MGOLMGO Global Inc
US$ 0,1019
(-38,73%)
70,51M
BACKIMAC Holdings Inc
US$ 0,7869
(-35,50%)
2,37M
EYENEyenovia Inc
US$ 0,03695
(-35,18%)
25,31M
HAOHaoxi Health Technology Ltd
US$ 2,52
(-31,89%)
484,94k
NVDANVIDIA Corporation
US$ 123,70
(-4,10%)
466,93M
SLXNSilexion Therapeutics Corporation
US$ 3,1301
(131,86%)
330,45M
OCEAOcean Biomedical Inc
US$ 0,249929
(-24,26%)
186,51M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,428
(-6,98%)
148,12M
RIMEAlgorhythm Holdings Inc
US$ 0,0259
(-16,18%)
138,96M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
DOMH
Dominari
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces